Tryptase activates isolated adult cardiac fibroblasts via protease activated receptor-2 (PAR-2)

Journal of Cell Communication and Signaling

Volumn 6, Issue 1, 2012, Pages 45-51

  Murray, David B ^a   McLarty Williams, Jennifer ^b   Nagalla, Krishna T ^a   Janicki, Joseph S ^b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

COX 2; FSLLRY; PAR 2; Prostaglandin

Indexed keywords

15 D PROSTAGLANDIN J2; CYCLOOXYGENASE 2; PROSTAGLANDIN J2; PROTEINASE ACTIVATED RECEPTOR 2; TRYPTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT;

RATTUS;

EID: 84863100556     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-011-0146-y     Document Type: Article

References (30)

1. Abbate A, Salloum FN, Ockaili RA, Fowler AA III, Biondi-Zoccai GG, Straino S et al (2007) Improvement of cardiac function with parecoxib, a cyclo-oxygenase-2 inhibitor, in a rat model of ischemic heart failure. J Cardiovasc Pharmacol 49:416-418 (Pubitemid 47000317)
2. Al-Ani B, Saifeddine M, Wijesuriya SJ, Hollenberg MD (2002) Modified proteinase-activated receptor-1 and -2 derived peptides inhibit proteinase-activated receptor-2 activation by trypsin. J Pharmacol Exp Ther 300:702-708
3. Baudino TA, Carver W, Giles W, Borg TK (2006) Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol 291:H1015-H1026 (Pubitemid 44343642)
4. Burgess ML, Terracio L, Hirozane T, Borg TK (2002) Differential integrin expression by cardiac fibroblasts from hypertensive and exercise-trained rat hearts. Cardiovasc Pathol 11:78-87 (Pubitemid 34273662)
5. de Almeida A, Mustin D, Forman MF, Brower GL, Janicki JS, Carver W (2002) Effects of mast cells on the behavior of isolated heart fibroblasts: modulation of collagen remodeling and gene expression. J Cell Physiol 191:51-59 (Pubitemid 34195217)
6. Edwards CA, O'Brien WD Jr (1980) Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin Chim Acta 104:161-167 (Pubitemid 10071550)
7. Frungieri MB, Weidinger S, Meineke V, Kohn FM, Mayerhofer A (2002) Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma: possible relevance to human fibrotic disorders. Proc Natl Acad Sci USA 99:15072-15077 (Pubitemid 35334611)
8. Frungieri MB, Albrecht M, Raemsch R, Mayerhofer A (2005) The action of the mast cell product tryptase on cyclooxygenase-2 (COX2) and subsequent fibroblast proliferation involves activation of the extracellular signal-regulated kinase isoforms 1 and 2 (erk1/2). Cell Signal 17:525-533 (Pubitemid 39643069)
9. Gailit J, Marchese MJ, Kew RR, Gruber BL (2001) The differentiation and function of myofibroblasts is regulated by mast cell mediators. J Investig Dermatol 117:1113-1119 (Pubitemid 34205906)
10. Hishikari K, Suzuki J, Ogawa M, Isobe K, Takahashi T, Onishi M et al (2009) Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury. Cardiovasc Res 81:123-132
11. Hudson M, Rahme E, Richard H, Pilote L (2007) Risk of congestive heart failure with nonsteroidal anti-inflammatory drugs and selective Cyclooxygenase 2 inhibitors: a class effect? Arthritis Rheum 57:516-523 (Pubitemid 46682542)
12. Jiang R, Zatta A, Kin H, Wang N, Reeves JG, Mykytenko J et al (2007) PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in in vivo rat hearts. Am J Physiol Heart Circ Physiol 293:H2845-H2852 (Pubitemid 350106507)
13. LaPointe MC, Mendez M, Leung A, Tao Z, Yang XP (2004) Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse. Am J Physiol Heart Circ Physiol 286: H1416-H1424 (Pubitemid 38381150)
14. Levi-Schaffer F, Piliponsky AM (2003) Tryptase, a novel link between allergic inflammation and fibrosis. Trends Immunol 24:158-161 (Pubitemid 36412097)
15. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R (2001) Proteinase-activated receptors. Pharmacol Rev 53:245-282 (Pubitemid 32476117)
16. Maree A, Fitzgerald D (2002) PAR2 is partout and now in the heart. Circ Res 90:366-368 (Pubitemid 34633901)
17. McLean PG, Aston D, Sarkar D, Ahluwalia A (2002) Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation: selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors, and C-fibers. Circ Res 90:465-472 (Pubitemid 34633917)
18. Mukherjee D (2008) Nonsteroidal anti-inflammatory drugs and the heart: what is the danger? Congest Heart Fail 14:75-82
19. Ossovskaya VS, Bunnett NW (2004) Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84:579-621 (Pubitemid 38365493)
20. Papanicolaou KN, Streicher JM, Ishikawa TO, Herschman H, Wang Y, Walsh K (2010) Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2. J Mol Cell Cardiol 49:196-209
21. Qian JY, Harding P, Liu Y, Shesely E, Yang XP, Lapointe MC (2008) Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction. Hypertension 51:560-566 (Pubitemid 351156448)
22. Ricks TK, Trejo J (2009) Phosphorylation of protease-activated receptor-2 differentially regulates desensitization and internalization. J Biol Chem 284:34444-34457
23. Saeed SA, Ahmed S (2006) Anti-ischemic effects of nimesulide, a cyclooxygenase-2 inhibitor on the ischemic model of rabbit induced by isoproterenol. Arch Pharm Res 29:977-983 (Pubitemid 44885775)
24. Skrabal CA, Thompson LO, Southard RE, Joyce DL, Noon GP, Loebe M et al (2004) Interaction between isolated human myocardial mast cells and cultured fibroblasts. J Surg Res 118:66-70 (Pubitemid 38490518)
25. Somasundaram P, Ren G, Nagar H, Kraemer D, Mendoza L, Michael LH et al (2005) Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts. J Pathol 205:102-111 (Pubitemid 40029098)
26. Steinberg SF (2005) The cardiovascular actions of protease-activated receptors. Mol Pharmacol 67:2-11 (Pubitemid 40069960)
27. Vichai V, Suyarnsesthakorn C, Pittayakhajonwut D, Sriklung K, Kirtikara K (2005) Positive feedback regulation of COX-2 expression by prostaglandin metabolites. Inflamm Res 54:163-172 (Pubitemid 41175267)
28. Wilson S, Greer B, Hooper J, Zijlstra A, Walker B, Quigley J et al (2005) The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells. Biochem J 388:967-972 (Pubitemid 40941585)
29. Xiao CY, Hara A, Yuhki K, Fujino T, Ma H, Okada Y et al (2001) Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia-reperfusion injury: a study using mice lacking their respective receptors. Circulation 104:2210-2215 (Pubitemid 33043302)
30. Yu H, Gallagher AM, Garfin PM, Printz MP (1997) Prostacyclin release by rat cardiac fibroblasts: inhibition of collagen expression. Hypertension 30:1047-1053 (Pubitemid 27476157)